Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-33
Closed -$621 5305
2026
Q1
$621 Sell
33
-61
-65% -$1.13K ﹤0.01% 4367
2025
Q4
$1.66K Hold
94
﹤0.01% 3904
2025
Q3
$3.19K Hold
94
﹤0.01% 3491
2025
Q2
$3.29K Buy
+94
New +$3.09K ﹤0.01% 3650
2023
Q4
Sell
-8
Closed -$194 3372
2023
Q3
$194 Hold
8
﹤0.01% 3199
2023
Q2
$222 Hold
8
﹤0.01% 3308
2023
Q1
$187 Sell
8
-1,000
-99% -$38.4K ﹤0.01% 3279
2022
Q4
$25K Buy
1,008
+8
+0.8% +$252 ﹤0.01% 2734
2022
Q3
$24K Buy
+1,000
New +$42.8K ﹤0.01% 2943
2019
Q1
Sell
-300
Closed -$7K 3508
2018
Q4
$7K Buy
+300
New +$5.56K ﹤0.01% 2713

Other funds holding ZLAB

IFP Advisors's ZLAB Position: Q2 2026 in Review

IFP Advisors sold out of Zai Lab (ZLAB) in Q2 2026, closing a stake of 33 shares — an estimated $621 sold.

IFP Advisors first reported a position in ZLAB in Q4 2018 and held it in 10 quarters. The position peaked at $25K in Q4 2022. 92 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

  • IFP Advisors reported no remaining Zai Lab position as of Q2 2026 after selling out during the quarter.
  • IFP Advisors sold 33 Zai Lab shares in Q2 2026, an estimated $621.
  • IFP Advisors first reported a position in Zai Lab in Q4 2018 and held it in 10 quarters.
  • IFP Advisors's Zai Lab position peaked at $25K in Q4 2022.
  • 92 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.